Alzheimer's disease dementia (ADD) is the most diffuse neurodegenerative disorder
belonging to mild cognitive impairment (MCI) and dementia in old persons. This disease is …

Electroencephalography (EEG) has shown potential for identifying early-stage biomarkers of
neurocognitive dysfunction associated with dementia due to Alzheimer's disease (AD). A …

Cerebrospinal and structural‐molecular neuroimaging in‐vivo biomarkers are
recommended for diagnostic purposes in Alzheimer's disease (AD) and other dementias; …

Acetylcholinesterase inhibitors (AChEIs) are the most widely used symptomatic treatment for
mild to severe Alzheimer's disease (AD) patients, while N-methyl-d-aspartic acid (NMDA) …

Alzheimer's disease (AD) is a devastating neurodegenerative dementing illness. Early
diagnosis at the prodromal stage is an important topic of current research. Significant …

Objective: To evaluate the relationship between some EEG spectral parameters and age of
onset of Alzheimer's disease (AD). Methods: A study on the wakefulness EEG, recorded …

In recent years, quantitative variables derived from the electroencephalogram (EEG) attract
an increasing interest for the evaluation of neurodegenerative diseases, as EEG registers …

Slowing of spontaneous alpha oscillations and an anterior shift of a source of alpha activity
(8–13 Hz) have been consistently reported in the EEG studies of Alzheimer's disease (AD). It …

Background To enable successful inclusion of electroencephalography (EEG) outcome
measures in Alzheimer's disease (AD) clinical trials, we retrospectively mapped the …

Objectives: The distinction between electroencephalogram (EEG) driving responses in
normal aging and Alzheimer's disease (AD) is unclear. This study was conducted to explore …